Safety of long-acting beta-agonists--an urgent need to clear the air

N Engl J Med. 2005 Dec 22;353(25):2637-9. doi: 10.1056/NEJMp058299.
No abstract available

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adrenergic beta-Agonists / adverse effects*
  • Adrenergic beta-Agonists / therapeutic use
  • Albuterol / adverse effects
  • Albuterol / analogs & derivatives*
  • Albuterol / therapeutic use
  • Asthma / drug therapy*
  • Asthma / mortality
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Ethanolamines / adverse effects*
  • Ethanolamines / therapeutic use
  • Formoterol Fumarate
  • Humans
  • Salmeterol Xinafoate
  • United Kingdom
  • United States

Substances

  • Adrenal Cortex Hormones
  • Adrenergic beta-Agonists
  • Ethanolamines
  • Salmeterol Xinafoate
  • Albuterol
  • Formoterol Fumarate